Navigation Links
Niusule Biotech Corp. to Commence Trading on the OTC Bulletin Board Under the Symbol 'NIUS'
Date:12/30/2008

CARSON CITY, Nev., Dec. 30 /PRNewswire-FirstCall/ -- Niusule Biotech Corp., a Nevada corporation formed on April 8, 2008, announced today that its shares of common stock will begin trading on the OTC Bulletin Board under the symbol "NIUS" on December 30th, 2008.

For a NIUS quote, visit: http://finance.yahoo.com/q?s=NIUS.OB

"Our main business will be operated in China through our subsidiary Zhejiang Baitai Bioengineering Corp by manufacturing and selling biopharmaceutical and health food," said Qinghua Hu, Chairman of Niusule Biotech Corp. "We believe our public listing is a signal of Niusule Biotech Corp.'s maturity as a company. I would like to thank Niusule Biotech Corp.'s partners, employees and shareholders for their respective roles in contributing to our success."

In a meeting with employees, directors, and shareholders, Hu discussed Niusule Biotech Corp. goals and priorities as a publicly traded entity including:

    -- Build long-term value for shareholders by implementing our business
       plan;
    -- Seek cooperation and alliance with US companies manufacturing health
       food products for either distribution or production rights in China;
       and
    -- Commitment to being a leading player in China's health food industry
       and bioengineering industry.

"As we are in our initial stages of growth, we provide both small and institutional investors opportunities to invest in China's health food industry," said Hu. "The move to the OTC Bulletin Board positions the company to benefit from greater visibility and liquidity."

About Niusule Biotech Corp.

Founded in 2008, Niusule Biotech Corp.'s main business will be operated in China through our subsidiary Zhejiang Baitai Bioengineering Corp. Niusule Biotech Corp. is trying to build a bridge between the USA and China in the health food industry and bioengineering industry by accessing the talent pools in both countries and by applying the mature technologies and high quality standards of the USA to its business model in China.

For more information about Niusule Biotech Corp., visit http://www.niusule.com.

This news release contains forward-looking statements. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted, or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks described in the company's filings with the SEC.


'/>"/>
SOURCE Niusule Biotech Corp.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Bolder BioTechnology Receives $1.9 Million NIH Grant to Continue Development of Long-Acting Growth Hormone Product
2. Epeius Biotech Awarded Patents in Europe for Targeted Genetic Anti-Cancer Medicine: Company Expands Impressive Intellectual Property Estate
3. Ganeden Biotech Receives Frost & Sullivan Probiotics Product Innovation Award
4. Oncolytics Biotech Inc.s REOLYSIN(R) Exceeds Primary Statistical Endpoint in U.S. Phase 2 Sarcoma Study
5. Biotechnology Value Fund Delivers Letter to Board of Directors of Avigen, Inc.
6. Axial Biotech Launches Genetic Test for Adolescent Idiopathic Scoliosis (AIS)
7. Investor Group Reconfigures Proposed Slate of Replacement Directors for Trinity Biotech
8. The MedZilla Report: October 2008 Employment Outlook for Biotech/Pharma/Health
9. Ernst & Young Benchmarks Danish Biotech Pipeline Third in Europe
10. Micromet Added to NASDAQ Biotechnology Index
11. Biotech Endorsement Insurance Discount Expanded to Nebraska, Kansas Growers Planting Corn with HERCULEX XTRA Traits
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/20/2017)... ... ... Biologist Dawn Maslar MS has found a biomarker that she claims verifies ... The Neuroscience of Meeting, Dating, Losing Your Mind, and Finding True Love, Maslar found ... step, in my estimation, was to scientifically track the evidence of commitment in men,” ...
(Date:6/20/2017)... ... June 20, 2017 , ... ... of antibody therapeutics from millions-diverse immune repertoires, announces launch of its new ... California. Dave Johnson, PhD, CEO of GigaGen, will present on Surge at the ...
(Date:6/16/2017)... ... June 16, 2017 , ... Cognition Corporation , ... two more sessions of its “From the Helm” Webinar Series. , The ... online templates for design control exercises. Led by David Cronin, Cognition’s CEO, the ...
(Date:6/15/2017)... Philadelphia, PA (PRWEB) , ... June 15, 2017 ... ... Center’s Esther Klein Gallery (EKG) follows an artist’s journey through creative experimentation and ... 22, 2017 and runs through July 22nd. An opening reception will be held ...
Breaking Biology Technology:
(Date:3/30/2017)... ANGELES , March 30, 2017  On April ... Hack the Genome hackathon at Microsoft,s ... exciting two-day competition will focus on developing health and ... Hack the Genome is the ... been tremendous. The world,s largest companies in the genomics, ...
(Date:3/27/2017)... ROCKVILLE CENTRE, N.Y. , March 27, 2017 ... by Healthcare Information and Management Systems Society (HIMSS) ... Analytics Outpatient EMR Adoption Model sm . In ... top 12% of U.S. hospitals using an electronic ... recognized CHS for its high level of EMR ...
(Date:3/22/2017)... VILNIUS, Lithuania , March 21, 2017 /PRNewswire/ ... identification and object recognition technologies, today announced the ... development kit (SDK), which provides improved facial recognition ... safety cameras on a single computer. The new ... algorithms to improve accuracy, and it utilizes a ...
Breaking Biology News(10 mins):